Author

Gajala Deethamvali Ghouse Peer

University of Petroleum and Energy Studies

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Jhalak SinghaliD· 2 shared Neha JhaiD· 2 shared Ramendra Pati PandeyiD· 2 shared Ruby Bansal· 2 shared Shailja SinghiD· 2 shared Aakriti Srivastava· 1 shared Aashima GuptaiD· 1 shared Anand RanganathaniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Jhalak SinghalORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyCommunications BiologyPeer-reviewedJun 11, 2026

Chemical degradation identified Human p38-MAPK as a host target to combat parasitic infections

Jhalak Singhal, Neha Rawat, Ruby Bansal…·Shailja Singh

This study shows that degrading host p38-MAPK with NR-7h reduces parasite load in Leishmania and Plasmodium infections and enhances antiparasitic therapy when combined with Amphotericin B.

2 citations

humanexperimental assay

𝕏 PostBluesky

PathologyInternational ImmunopharmacologyPeer-reviewedFeb 20, 2025

Evaluation of Immunopharmacological Efficacy of Live Leishmania donovani Overexpressing Ld_ζ1domain for Protection Against Experimental Human Visceral Leishmaniasis

Ruby Bansal, Sadat Shafi, Prachi Garg…·Shailja Singh

This study evaluates the immunopharmacological efficacy of Leishmania donovani overexpressing Ld_ζ1domain as a vaccine candidate against visceral leishmaniasis, showing reduced parasite burden and enhanced immune response.

DOI 10.1016/j.intimp.2025.114295

mousebulk RNA-seq

𝕏 PostBluesky